Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bordignon

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Nature|July 1, 2006
Stem-cell therapies for blood diseasesClaudio Bordignon
Journal of Autoimmunity|July 21, 2017
Twenty-five years of gene therapy for genetic diseases and leukemia: The road to marketing authorization of the first ex vivo gene therapiesClaudio Bordignon
Nature Immunology|September 30, 2003
Unplugging the T cell receptorGuido Poli, Claudio Bordignon
International Journal of Hematology|December 5, 2002
Suicide-gene-Transduced donor T-cells for controlled graft-versus-host disease and graft-versus-tumorFabio Ciceri, Claudio Bordignon
Nature Immunology|March 29, 2002
Therapeutic applications for hematopoietic stem cell gene transferClaudio Bordignon, Maria Grazia Roncarolo
Blood|May 28, 2009
NGR and isoDGR are separate moieties binding to different receptorsGian-Paolo Rizzardi, Claudio Bordignon
Journal of Cardiothoracic and Vascular Anesthesia|August 25, 2011
Extracorporeal membrane oxygenation: a new way to study toxic drugs in chronic diseasesGiovanni Landoni, Massimiliano Greco, Laura Ruggeri, et al.
Current Opinion in Allergy and Clinical Immunology|November 13, 2003
Gene therapy for adenosine deaminase deficiencyAlessandro Aiuti, Francesca Ficara, Federica Cattaneo, et al.
European Journal of Immunology|September 5, 2002
Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokinesRosa Bacchetta, Claudia Sartirana, Megan K Levings, et al.
Haematologica|April 13, 2004
Efficient gene transfer into primitive hematopoietic progenitors using a bone marrow microenvironment cell line engineered to produce retroviral vectorsJonathan S Dando, Francesca Ficara, Sara Deola, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Nature|July 1, 2006
Stem-cell therapies for blood diseasesClaudio Bordignon
Journal of Autoimmunity|July 21, 2017
Twenty-five years of gene therapy for genetic diseases and leukemia: The road to marketing authorization of the first ex vivo gene therapiesClaudio Bordignon
Nature Immunology|September 30, 2003
Unplugging the T cell receptorGuido Poli, Claudio Bordignon
International Journal of Hematology|December 5, 2002
Suicide-gene-Transduced donor T-cells for controlled graft-versus-host disease and graft-versus-tumorFabio Ciceri, Claudio Bordignon
Nature Immunology|March 29, 2002
Therapeutic applications for hematopoietic stem cell gene transferClaudio Bordignon, Maria Grazia Roncarolo
Blood|May 28, 2009
NGR and isoDGR are separate moieties binding to different receptorsGian-Paolo Rizzardi, Claudio Bordignon
Journal of Cardiothoracic and Vascular Anesthesia|August 25, 2011
Extracorporeal membrane oxygenation: a new way to study toxic drugs in chronic diseasesGiovanni Landoni, Massimiliano Greco, Laura Ruggeri, et al.
Current Opinion in Allergy and Clinical Immunology|November 13, 2003
Gene therapy for adenosine deaminase deficiencyAlessandro Aiuti, Francesca Ficara, Federica Cattaneo, et al.
European Journal of Immunology|September 5, 2002
Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokinesRosa Bacchetta, Claudia Sartirana, Megan K Levings, et al.
Haematologica|April 13, 2004
Efficient gene transfer into primitive hematopoietic progenitors using a bone marrow microenvironment cell line engineered to produce retroviral vectorsJonathan S Dando, Francesca Ficara, Sara Deola, et al.
Pageof 10